INS and hypertriglyceridemia: Intergroup comparison of routine clinical laboratory data revealed significant differences in total triglyceride levels, along with fasting and glucose-stimulated serum insulin but not glucose level among these metabotypes (Figure 4; Table 4), with individuals in metabotype 3 showing lower insulin sensitivity and hypertriglyceridemia, in a higher risk metabolic profile than patients in metabotypes 1 and 2.